Search
forResearch 10 of 678
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- 5α-Reductase activity in the human hair follicle concentrates in the dermal papilla
Community 3 of 4
- Still losing on fin 5x & dut 2x p/w (1.5 years in) - next steps advice
- Dutasteride worked at 3x/week, then paradoxically got worse after upping to 5x/week — DHT went UP, not down
- High Estrogen and Test on Dut 5x a week
Learn
— no results
Try a deeper search in learn →